Identification of the rat homologue of KAI1 and its expression in dunning rat prostate cancers

Hiroyoshi Suzuki, Jin Tang Dong, Allen Chuan Gao, J. Carl Barrett, John Tod Isaacs

Research output: Contribution to journalArticle

Abstract

BACKGROUND. We previously isolated the human KAI1 gene encoding a transmembrane protein which suppresses metastatic ability in Dunning R3327 AT6.1 rat prostate cancer cells when transfected into these cells. The AT6.1 subline is one of the more aggressive sublines among the Dunning R-3327 system of rat prostate cancers. This raises the issue of whether downregulation of KAI1 expression consistently occurs during the acquisition of high metastatic ability by members of the Dunning system of rat prostate cancers. METHODS. To investigate this possibility, the rat homologue of the KAI1 gene was identified, using a combination of cDNA library screening and 5'-RACE and DNA sequencing. Based on this information, a rat-specific cDNA probe was developed and used for Northern blot analysis of KAI1 expression in normal rat tissues and a series of sublines of Dunning R3327 cells that vary widely in their metastatic abilities. RESULTS. The rat KAI1 gene encoded a protein of 266 amino acids which has 77% identity to the human KAI1 protein. In normal tissues, KAI1 is expressed predominantly as a 2.0-kb-sized transcript. Several tissues (e.g., skeletal muscle and prostate) also express a minor 1.8-kb-sized RNA. Northern blot analysis of a series of Dunning sublines demonstrated that all sublines expressed both the 2.0- and 1.8-kb KAI1 RNA transcripts. However, quantitative levels of the 2.0- vs. 1.8-kb KAI1 RNA were variable among sublines. Downregulation of expression of the 2.0-kb KAI1 transcript was statistically correlated with the acquisition of high metastatic ability within this system of prostate cancer sublines. In contrast, the 1.8-kb transcript was upregulated in all of the more aggressive sublines, but this enhanced expression was not specifically correlated with metastatic ability. CONCLUSIONS. These studies demonstrated that downregulation of the 2.0-kb KAI1 mRNA is associated with the acquisition of high metastatic ability by prostate cancer cells.

Original languageEnglish (US)
Pages (from-to)253-260
Number of pages8
JournalProstate
Volume37
Issue number4
DOIs
StatePublished - Dec 1 1998

Fingerprint

Prostatic Neoplasms
Down-Regulation
RNA
Northern Blotting
Genes
Gene Library
DNA Sequence Analysis
Prostate
Skeletal Muscle
Proteins
Complementary DNA
Amino Acids
Messenger RNA

Keywords

  • Dunning tumors
  • KAI1
  • Metastasis suppressor gene
  • Prostate cancer

ASJC Scopus subject areas

  • Urology

Cite this

Identification of the rat homologue of KAI1 and its expression in dunning rat prostate cancers. / Suzuki, Hiroyoshi; Dong, Jin Tang; Gao, Allen Chuan; Barrett, J. Carl; Isaacs, John Tod.

In: Prostate, Vol. 37, No. 4, 01.12.1998, p. 253-260.

Research output: Contribution to journalArticle

Suzuki, Hiroyoshi ; Dong, Jin Tang ; Gao, Allen Chuan ; Barrett, J. Carl ; Isaacs, John Tod. / Identification of the rat homologue of KAI1 and its expression in dunning rat prostate cancers. In: Prostate. 1998 ; Vol. 37, No. 4. pp. 253-260.
@article{9e770c9a8f6d467dae1d3f3e823a16d0,
title = "Identification of the rat homologue of KAI1 and its expression in dunning rat prostate cancers",
abstract = "BACKGROUND. We previously isolated the human KAI1 gene encoding a transmembrane protein which suppresses metastatic ability in Dunning R3327 AT6.1 rat prostate cancer cells when transfected into these cells. The AT6.1 subline is one of the more aggressive sublines among the Dunning R-3327 system of rat prostate cancers. This raises the issue of whether downregulation of KAI1 expression consistently occurs during the acquisition of high metastatic ability by members of the Dunning system of rat prostate cancers. METHODS. To investigate this possibility, the rat homologue of the KAI1 gene was identified, using a combination of cDNA library screening and 5'-RACE and DNA sequencing. Based on this information, a rat-specific cDNA probe was developed and used for Northern blot analysis of KAI1 expression in normal rat tissues and a series of sublines of Dunning R3327 cells that vary widely in their metastatic abilities. RESULTS. The rat KAI1 gene encoded a protein of 266 amino acids which has 77{\%} identity to the human KAI1 protein. In normal tissues, KAI1 is expressed predominantly as a 2.0-kb-sized transcript. Several tissues (e.g., skeletal muscle and prostate) also express a minor 1.8-kb-sized RNA. Northern blot analysis of a series of Dunning sublines demonstrated that all sublines expressed both the 2.0- and 1.8-kb KAI1 RNA transcripts. However, quantitative levels of the 2.0- vs. 1.8-kb KAI1 RNA were variable among sublines. Downregulation of expression of the 2.0-kb KAI1 transcript was statistically correlated with the acquisition of high metastatic ability within this system of prostate cancer sublines. In contrast, the 1.8-kb transcript was upregulated in all of the more aggressive sublines, but this enhanced expression was not specifically correlated with metastatic ability. CONCLUSIONS. These studies demonstrated that downregulation of the 2.0-kb KAI1 mRNA is associated with the acquisition of high metastatic ability by prostate cancer cells.",
keywords = "Dunning tumors, KAI1, Metastasis suppressor gene, Prostate cancer",
author = "Hiroyoshi Suzuki and Dong, {Jin Tang} and Gao, {Allen Chuan} and Barrett, {J. Carl} and Isaacs, {John Tod}",
year = "1998",
month = "12",
day = "1",
doi = "10.1002/(SICI)1097-0045(19981201)37:4<253::AID-PROS7>3.0.CO;2-3",
language = "English (US)",
volume = "37",
pages = "253--260",
journal = "Prostate",
issn = "0270-4137",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Identification of the rat homologue of KAI1 and its expression in dunning rat prostate cancers

AU - Suzuki, Hiroyoshi

AU - Dong, Jin Tang

AU - Gao, Allen Chuan

AU - Barrett, J. Carl

AU - Isaacs, John Tod

PY - 1998/12/1

Y1 - 1998/12/1

N2 - BACKGROUND. We previously isolated the human KAI1 gene encoding a transmembrane protein which suppresses metastatic ability in Dunning R3327 AT6.1 rat prostate cancer cells when transfected into these cells. The AT6.1 subline is one of the more aggressive sublines among the Dunning R-3327 system of rat prostate cancers. This raises the issue of whether downregulation of KAI1 expression consistently occurs during the acquisition of high metastatic ability by members of the Dunning system of rat prostate cancers. METHODS. To investigate this possibility, the rat homologue of the KAI1 gene was identified, using a combination of cDNA library screening and 5'-RACE and DNA sequencing. Based on this information, a rat-specific cDNA probe was developed and used for Northern blot analysis of KAI1 expression in normal rat tissues and a series of sublines of Dunning R3327 cells that vary widely in their metastatic abilities. RESULTS. The rat KAI1 gene encoded a protein of 266 amino acids which has 77% identity to the human KAI1 protein. In normal tissues, KAI1 is expressed predominantly as a 2.0-kb-sized transcript. Several tissues (e.g., skeletal muscle and prostate) also express a minor 1.8-kb-sized RNA. Northern blot analysis of a series of Dunning sublines demonstrated that all sublines expressed both the 2.0- and 1.8-kb KAI1 RNA transcripts. However, quantitative levels of the 2.0- vs. 1.8-kb KAI1 RNA were variable among sublines. Downregulation of expression of the 2.0-kb KAI1 transcript was statistically correlated with the acquisition of high metastatic ability within this system of prostate cancer sublines. In contrast, the 1.8-kb transcript was upregulated in all of the more aggressive sublines, but this enhanced expression was not specifically correlated with metastatic ability. CONCLUSIONS. These studies demonstrated that downregulation of the 2.0-kb KAI1 mRNA is associated with the acquisition of high metastatic ability by prostate cancer cells.

AB - BACKGROUND. We previously isolated the human KAI1 gene encoding a transmembrane protein which suppresses metastatic ability in Dunning R3327 AT6.1 rat prostate cancer cells when transfected into these cells. The AT6.1 subline is one of the more aggressive sublines among the Dunning R-3327 system of rat prostate cancers. This raises the issue of whether downregulation of KAI1 expression consistently occurs during the acquisition of high metastatic ability by members of the Dunning system of rat prostate cancers. METHODS. To investigate this possibility, the rat homologue of the KAI1 gene was identified, using a combination of cDNA library screening and 5'-RACE and DNA sequencing. Based on this information, a rat-specific cDNA probe was developed and used for Northern blot analysis of KAI1 expression in normal rat tissues and a series of sublines of Dunning R3327 cells that vary widely in their metastatic abilities. RESULTS. The rat KAI1 gene encoded a protein of 266 amino acids which has 77% identity to the human KAI1 protein. In normal tissues, KAI1 is expressed predominantly as a 2.0-kb-sized transcript. Several tissues (e.g., skeletal muscle and prostate) also express a minor 1.8-kb-sized RNA. Northern blot analysis of a series of Dunning sublines demonstrated that all sublines expressed both the 2.0- and 1.8-kb KAI1 RNA transcripts. However, quantitative levels of the 2.0- vs. 1.8-kb KAI1 RNA were variable among sublines. Downregulation of expression of the 2.0-kb KAI1 transcript was statistically correlated with the acquisition of high metastatic ability within this system of prostate cancer sublines. In contrast, the 1.8-kb transcript was upregulated in all of the more aggressive sublines, but this enhanced expression was not specifically correlated with metastatic ability. CONCLUSIONS. These studies demonstrated that downregulation of the 2.0-kb KAI1 mRNA is associated with the acquisition of high metastatic ability by prostate cancer cells.

KW - Dunning tumors

KW - KAI1

KW - Metastasis suppressor gene

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=0031758519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031758519&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0045(19981201)37:4<253::AID-PROS7>3.0.CO;2-3

DO - 10.1002/(SICI)1097-0045(19981201)37:4<253::AID-PROS7>3.0.CO;2-3

M3 - Article

C2 - 9831222

AN - SCOPUS:0031758519

VL - 37

SP - 253

EP - 260

JO - Prostate

JF - Prostate

SN - 0270-4137

IS - 4

ER -